PPAR-ϒ pathway to vascular dysfunction.
Humans with dominant-negative (DN) mutations in PPAR-ϒ develop early onset hypertension. A recent study by Pelham et al. (2012) shows that loss of PPAR-ϒ repression of the Rho kinase pathway leads to altered vascular function via a smooth-muscle-dependent pathway that is independent of NO and oxidant stress.